Physician profile
Adil Cheema
NPI 1174009153
$4,219.60
in general payments reported to CMS, 2019-2025
20 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,071 · 2022: $658 · 2023: $803 · 2024: $173 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,008.51 | 2021 | |
| Merck Sharp & Dohme LLC | $250.07 | 2023-2025 | Verquvo |
| Astellas Pharma US INC | $224.87 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.46 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $197.13 | 2022-2025 | |
| Shockwave Medical, INC | $186.66 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $168.37 | 2025 | |
| Abbott Laboratories | $150.00 | 2023 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.90 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $136.13 | 2021-2025 | Latitude Communicator Power Supply, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Bard Peripheral Vascular, INC. | $134.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $122.97 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $64.34 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $56.67 | 2025 | Camzyos |
| Novo Nordisk INC | $44.03 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.00 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $26.93 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $19.87 | 2023 | Definity |
| Scpharmaceuticals INC. | $15.41 | 2024 | |
| Amgen INC. | $13.50 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.